As soon as the outbreak of COVID-19, BOYA immediately called on its staff to support and cooperate with the pandemic prevention and control work with practical actions. On the other hand, senior executives deployed early resumption of antiviral drugs production via video conference.

BOYA allocated more than 200 million yuan of drug supply to ensure the sufficient supply of human immunoglobulin for first-line virus control in Hubei, Jiangxi, Guangdong provinces. Meanwhile, on the first day of Chinese lunar year, BOYA contacted cold chain logistics companies for emergency delivery to help fight the pandemic.

At the same time, BOYA actively organized marketing departments donation around the country. According to statistics, BOYA has donated human immunoglobulin of more than 5 million yuan to designated core hospitals in Hubei, Jiangxi and Guangdong. In addition, mask, protective clothing, alcohol and other medical materials have also been sent to the front line.

Reported by Boya biopharmaceutical Group Co., Ltd

Translated by YE Xiayan;

Reviewed by MA Ling, JIANG Nizhen